Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Effect of NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, on neurotransmitter receptor systems in aged rats.

European journal of neurology

Araki T, Itoyama Y, Kato H, Oshima Y, Shuto K.
PMID: 10210896
Eur J Neurol. 1998 Nov;5(6):601-608. doi: 10.1046/j.1468-1331.1998.560601.x.

In order to examine the effect of age and nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), we studied the changes on major neurotransmitter receptor systems in 6 (adult) and 24-month-old (aged) Fischer male rats using receptor autoradiography. L-NAME...

Cite
Araki T, Itoyama Y, Kato H, et al. Effect of NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, on neurotransmitter receptor systems in aged rats. Eur J Neurol. 1998;5(6):601-608doi: 10.1046/j.1468-1331.1998.560601.x.
Araki, T., Itoyama, Y., Kato, H., Oshima, Y., & Shuto, K. (1998). Effect of NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, on neurotransmitter receptor systems in aged rats. European journal of neurology, 5(6), 601-608. https://doi.org/10.1046/j.1468-1331.1998.560601.x
Araki, et al. "Effect of NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, on neurotransmitter receptor systems in aged rats." European journal of neurology vol. 5,6 (1998): 601-608. doi: https://doi.org/10.1046/j.1468-1331.1998.560601.x
Araki T, Itoyama Y, Kato H, Oshima Y, Shuto K. Effect of NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, on neurotransmitter receptor systems in aged rats. Eur J Neurol. 1998 Nov;5(6):601-608. doi: 10.1046/j.1468-1331.1998.560601.x. PMID: 10210896.
Copy Download .nbib Format: NLM
Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Tadokoro S, Nonomura N, Kanahara N, Hashimoto K, Iyo M.
PMID: 28138118
Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):79-81. doi: 10.9758/cpn.2017.15.1.79.

Dopamine supersensitivity psychosis (DSP) is a type of acute exacerbation of recurrent psychosis caused by long-term treatment with antipsychotics in schizophrenic patients. Although DSP is exceedingly troublesome for clinicians, effective treatment has not yet been established. Based on clinical...

Cite
Tadokoro S, Nonomura N, Kanahara N, et al. Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report. Clin Psychopharmacol Neurosci. 2017;15(1):79-81doi: 10.9758/cpn.2017.15.1.79.
Tadokoro, S., Nonomura, N., Kanahara, N., Hashimoto, K., & Iyo, M. (2017). Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 15(1), 79-81. https://doi.org/10.9758/cpn.2017.15.1.79
Tadokoro, Shigenori, et al. "Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 15,1 (2017): 79-81. doi: https://doi.org/10.9758/cpn.2017.15.1.79
Tadokoro S, Nonomura N, Kanahara N, Hashimoto K, Iyo M. Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report. Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):79-81. doi: 10.9758/cpn.2017.15.1.79. PMID: 28138118; PMCID: PMC5290712.
Copy Download .nbib Format: NLM
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.

Supportive cancer therapy

Reddy GK, Gralla RJ, Hesketh PJ.
PMID: 18632487
Support Cancer Ther. 2006 Apr 01;3(3):140-2. doi: 10.3816/SCT.2006.n.011.

Despite significant advances in supportive care in oncology, many patients with cancer still experience chemotherapy- induced nausea and vomiting (CINV). Historically, there were only 3 neurotransmitter receptors (dopamine D2, cannabinoid- 1, and 5-hydroxytryptamine-3) that were the known targets for...

Cite
Reddy GK, Gralla RJ, Hesketh PJ. Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Support Cancer Ther. 2006;3(3):140-2doi: 10.3816/SCT.2006.n.011.
Reddy, G. K., Gralla, R. J., & Hesketh, P. J. (2006). Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Supportive cancer therapy, 3(3), 140-2. https://doi.org/10.3816/SCT.2006.n.011
Reddy, G Kesava, et al. "Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis." Supportive cancer therapy vol. 3,3 (2006): 140-2. doi: https://doi.org/10.3816/SCT.2006.n.011
Reddy GK, Gralla RJ, Hesketh PJ. Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Support Cancer Ther. 2006 Apr 01;3(3):140-2. doi: 10.3816/SCT.2006.n.011. PMID: 18632487.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries